FDA Writes Pandemic Test Playbook For Next Disease Outbreak
Published Date: 1/7/2025
Notice
Summary
The FDA just dropped a draft guide to help companies quickly test new lab devices that spot emerging germs during health emergencies. This guide shows how to prove these tests work before or during an emergency, making it easier and faster to get them approved. If you make or use these tests, check it out and send your thoughts by March 10, 2025—no extra costs yet, but it could speed things up big time!
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Draft IVD Validation Guidance
If you make in vitro diagnostic (IVD) tests for emerging pathogens, the FDA released a draft guidance that explains general recommendations for how to validate those tests during a Section 564 declared public health emergency. The recommendations apply to data submitted in a pre-Emergency Use Authorization (pre-EUA), an EUA request, or to tests offered under an applicable enforcement discretion policy; the FDA is accepting comments on the draft through March 10, 2025.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Take It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in